Skip to main content
Gaush Meditech Ltd logo

Gaush Meditech Ltd — Investor Relations & Filings

Ticker · 2407 LEI · 254900I4OJB732KGP619 HKEX Manufacturing
Open in API
Filings indexed 163 across all filing types
Latest filing 2025-08-04 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2407

About Gaush Meditech Ltd

http://www.gaush.com

Gaush Meditech Ltd. is a technology group dedicated to the ophthalmic medical sector, integrating research and development, manufacturing, sales, training, and technical services. The company provides a broad spectrum of high-quality ophthalmic medical devices, equipment, and consumables. Its comprehensive portfolio includes diagnostic equipment, surgical instruments, and treatment devices, serving the specialized needs of eye care professionals. The company leverages over two decades of experience in this field.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT FREQUENCY-DOMAIN BIOMETER OBTAINED MEDICAL DEVICE REGISTRATION CERTIFICATE IN CHINA
Regulatory Filings Classification · 1% confidence The document is a “Voluntary Announcement” regarding a subsidiary obtaining a medical device registration certificate in China. It does not present financial results (ER, IR, 10-K), management discussion (MDA), board changes (MANG), share transactions (POS, DIRS), capital actions (CAP, SHA), proxy materials (PSI), or other specific categories. It is a standalone corporate announcement (short, <5,000 chars) with no report attached or published. Therefore it falls into the fallback category for miscellaneous regulatory announcements: Regulatory Filings (RNS).
2025-08-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2025
Share Issue/Capital Change Classification · 1% confidence The document is a Hong Kong Exchange (HKEX) Form FF301 monthly return detailing movements in the issuer’s authorised, issued and treasury shares (no change month-end balances). It is a regulatory submission on share capital and issuance/repurchase activity. This aligns with the Share Issue/Capital Change category (SHA), which covers announcements and filings concerning share capital movements.
2025-08-01 English
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE SHARE AWARD SCHEME
Transaction in Own Shares Classification · 1% confidence The document is a voluntary announcement informing shareholders that the Trustee has purchased the Company’s own shares in the market under the share award scheme. This is clearly a report of the company (through its Trustee) buying back its own shares. It does not announce a dividend, takeover, management changes, or file an interim or annual report, nor is it a publication announcement of a report. It falls squarely under “Transaction in Own Shares” (POS).
2025-07-28 English
VOLUNTARY ANNOUNCEMENT CORNEAL CONTACT LENS OBTAINED MEDICAL DEVICE REGISTRATION CERTIFICATE IN CHINA
Regulatory Filings Classification · 1% confidence The document is a voluntary announcement by Gaush Meditech Ltd informing shareholders and investors that a subsidiary has obtained a medical device registration certificate in China. It is a corporate business development update rather than a financial report, earnings release, M&A notice, management change, dividend, or detailed report. No specific form or regulatory filing name is cited (e.g., 10-K, interim report, proxy statement). It does not announce publication of a formal report, but rather communicates a regulatory approval for a product. Therefore, it falls into the generic “Regulatory Filings” category (RNS) for miscellaneous exchange announcements that do not fit other specific types.
2025-07-17 English
VOLUNTARY ANNOUNCEMENT DISPOSABLE ULTRASONIC EMULSIFICATION VITRECTOMY IRRIGATION-ASPIRATION TUBING KIT OBTAINED MEDICAL DEVICE REGISTRATION CERTIFICATE IN CHINA
Regulatory Filings Classification · 1% confidence The document is a voluntary business announcement by a Hong Kong-listed company regarding a subsidiary obtaining a medical device registration certificate. It is not a financial report, management change, earnings release, or other specific category. It serves as a general regulatory announcement and thus falls into the catch-all Regulatory Filings (RNS) category.
2025-07-14 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2025
Regulatory Filings Classification · 1% confidence The document is a standardized ‘Monthly Return for Equity Issuer and Hong Kong Depositary Receipts’ (Form FF301) filed under HKEX Listing Rules detailing authorised and issued share capital movements for the month. It solely provides regulatory compliance data on share capital and contains no financial results, earnings commentary, AGM materials, management changes, or legal notices. This form does not constitute an annual or interim report, earnings release, or capital issuance announcement in the conventional sense. It is a routine regulatory submission under the Exchange Listing Rules, fitting the “Regulatory Filings” fallback category.
2025-07-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.